跳至主要内容
临床试验/NCT03372447
NCT03372447已完成4 期

Megadose of Hydroxocobalamin (Vitamin B12) for the Treatment of Pernicious Anemia

Hospital Universitario Dr. Jose E. Gonzalez1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2017年12月27日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
13
试验地点
1
主要终点
Hematologic response

研究概览

简要总结

Demonstrate the effectiveness of a single dose of a multivitamin complex for the treatment of megaloblastic anemia

详细描述

The investigators will administrate a single intramuscular dose of hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg.

To assess response to treatment, a complete blood count (CBC) will be performed weekly during the first month of treatment, after the first month a CBC will be taken monthly for 6 months.

Also to confirm the diagnosis and assess response the investigators will measure levels of methylmalonic acid, homocysteine, and hydroxocobalamin at the beginning of the study, 3 and 6 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18, All sex Clinical suspicious of megaloblastic anemia ( cytopenias and macrocytosis (CBC), hypersegmented neutrophils and elevated lactate dehydrogenase) Patients must sign an informed consent indicating that they are aware of the investigational nature of this study -

排除标准

  • Administration of hydroxocobalamin in the three years before enrollment Patients with active, uncontrolled psychiatric disorders Severe neurologic deficit Known hematologic malignancy Known coagulation disorder that contraindicates intramuscular injection End-stage kidney disease (GFR <15ml/min) Chronic liver disease (Child-Pugh B or C) Pregnant patients Known infection of Hepatitis B or C and HIV Diagnosis of myelodysplastic syndrome

研究组 & 干预措施

Megadose multivitamin complex

Experimental

Intramuscular injection of hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg

干预措施: Hydroxocobalamin 10,000mcg, Thiamin 100mg, Pyridoxine 50mg (Drug)

结局指标

主要结局

Hematologic response

时间窗: 2 month

Normalization of complete blood count (CBC).

Duration of hematologic response

时间窗: 6 months

Duration of response (months) after the administration of megadose of hydroxocobalamin

次要结局

  • Measure levels of hydroxocobalamin(Basal, three and six months)
  • Measure levels of methylmalonic acid.(Basal, three and six months)
  • Evaluate time to hematologic response(1 month)
  • Measure levels of homocysteine.(Basal, three and six months)

研究者

发起方
Hospital Universitario Dr. Jose E. Gonzalez
申办方类型
Other
责任方
Principal Investigator
主要研究者

David Gomez Almaguer

Principal Investigator / Head of Hematology Department/MD

Hospital Universitario Dr. Jose E. Gonzalez

研究点 (1)

Loading locations...

相似试验